Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003

Alan Johnson*, Theresa Lamagni, Martin Wale, Sue Cavendish, Louise Bishop, Neelam Alhaddad, Marina Warner, David M. Livermore, Georgia Duckworth, Robert George

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK.

Original languageEnglish
Pages (from-to)539-541
Number of pages3
JournalInternational Journal of Antimicrobial Agents
Volume25
Issue number6
DOIs
Publication statusPublished - Jun 2005

Bibliographical note

Funding Information:
EARSS is funded by the European Commission DG Sanco (Agreement S12.123794). The EARSS Collaborating Group for this study comprised Dr D. Brown (Addenbrooke's NHS Trust), Dr P. Cockcroft (Portsmouth Hospitals), Dr T. Collyns (St James's University Hospital–Teaching Hospitals NHS Trust, Leeds), Dr S. Cotterill, Dr M. Misra, Mr D. Dicks (Salisbury Health Care NHS Trust), Dr P. Godwin, Mrs G. McAndrew (Airedale General Hospital, Keighley), Dr A. Johnson, Dr M. Wilson, Mrs V.A. Cook (The County Hospital, Hereford Hospitals NHS Trust), Dr K. Loudon (Pilgrim Hospital, Boston), Dr A. Lowes, Mr A. Tuck (Southampton University Hospitals Trust), Dr N. Manek (The George Eliot Hospital NHS Trust), Dr P. Mannion (Countess of Chester NHS Trust), Dr J. Nash (East Kent NHS Trust), Dr P.B. Nielsen (Peterborough and Stamford Hospitals NHS Foundation Trust), Dr M. Osman (Barnsley District General NHS Trust), Dr J. Perry, Miss A. Nicholson (Freeman Hospital, Newcastle), Dr S. Pugh, Mr P. Cheetham, Miss J. Palfreyman (Department of Microbiology for University Hospital and City Hospital Nottingham), Dr R. Spencer, Ms G.M. Wilson (Health Protection Agency South West Regional Laboratory, Bristol), Dr J. Stockley (Worcestershire Royal Hospital), Dr A. Telfer Brunton, Mr J. Rogers (Royal Cornwall Hospitals Trust), Dr N. Weightman (Friarage Hospital, Northallerton), and Dr E. Youngs and Mr J. McCluskie (Lincoln County Hospital).

Keywords

  • Quinolones
  • Streptococcus pneumoniae
  • Susceptibility testing

Fingerprint

Dive into the research topics of 'Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003'. Together they form a unique fingerprint.

Cite this